Here are six takeaways:
1. The market is expected to grow at a compound annual growth rate of 8 percent to 2018.
2. The increasing prevalence of chronic diseases as well as a growing aging population will spur market growth.
3. Other market drivers include an increasing healthcare expenditure and purchasing power parity.
4. The costliness of implantable devices, however, will serve as a barrier to market growth.
5. The orthopedic segment is leading the market, set to reach revenue of $38.04 million by 2018.
6. Zimmer Biomet, Stryker and Abbott Laboratories lead the market.
More articles on devices:
Massachusetts orthopedic surgeons receive $33M on hip devices: 4 key notes
Titan Spine launches nanoLOCK surface technology nationwide: 5 highlights
Dr. Raphael Roybal to share experience with FLXfit expandable cage: 3 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
